Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 48% Improvement Relative Risk Vitamin D for COVID-19  Tehrani et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 205 patients in Iran Lower mortality with higher vitamin D levels (not stat. sig., p=0.065) c19early.org Tehrani et al., Clinical Nutrition, Jan 2021 Favors vitamin D Favors control

Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality

Tehrani et al., Clinical Nutrition, doi:10.1016/j.clnesp.2021.01.014
Jan 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Retrospective 205 patients in Iran, showing higher mortality with vitamin D deficiency, not quite reaching statistical significance.
This is the 44th of 196 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 11,637 vigintillion).
risk of death, 47.5% lower, RR 0.52, p = 0.07, high D levels 34 of 180 (18.9%), low D levels 9 of 25 (36.0%), NNT 5.8, >10ng/ml.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Tehrani et al., 25 Jan 2021, retrospective, Iran, peer-reviewed, 5 authors.
This PaperVitamin DAll
Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality
Shabnam Tehrani, Neda Khabiri, Hamideh Moradi, Mina Sadat Mosavat, Seyyed Saeed Khabiri
Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.01.014
Background and aims: Novel Coronavirus (COVID-19) first appeared in China in late 2019 which was rapidly spread worldwide. As the COVID-19 pandemic continues to spread, it is crucial to determine the prognostic factors contributing to the development of severe disease and higher mortality. Herein we aimed to evaluate the correlation between the severity and prognosis of patients with COVID 19 with serum 25(OH)D levels. Method: This descriptive retrospective study was performed from March to April 2020 at a referral center for patients with COVID-19, Tehran, Iran. The data collection was performed by a checklist consisting of the demographic features and laboratory assessments consisted of serum 25(OH)D were evaluated and recorded. And investigate the relationship between serum 25(OH)D and clinical outcomes of patients. Result: 205 patients with a mean age of 59.71 years were enrolled. Our findings did not reveal a significant difference in mean levels of vitamin between improved (34.09) and deceased patients (34.54). However, in patients with severe disease, there was a considerable difference in levels of vitamin D in improved and deceased patients (P.value: 0.021). According to our results, the mortality rate was slightly higher in men (odds ratio:2.2). Furthermore, the mean age (64.20 vs. 58.51) and the presence of at least two comorbidities (odds ratio: 2.40) were significantly higher in deceased patients. Conclusion: In this study, we did not reveal a statistical difference in mean levels of vitamin D and the outcome of patients with COVID-19. We concluded that in patients with severe disease, vitamin D deficiency could affect the course of the disease and mortality, especially in comorbidity and older people.
Declaration of competing interest The authors did not declare any conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
References
Bernheim, Mei, Huang, Yang, Fayad et al., Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection, Radiology
Bhatraju, Ghassemieh, Nichols, Kim, Jerome et al., Covid-19 in critically ill patients in the Seattle regiondcase series, N Engl J Med
Brown, Sarkar, Vitamin D deficiency: a factor in COVID-19, progression, severity and mortality?eAn urgent call for research, MitoFit Preprint Arch
Buta, Choudhury, Xue, Chaves, Bandeen-Roche et al., The association of vitamin D deficiency and incident frailty in older women: the role of cardiometabolic diseases, J Am Geriatr Soc
Camargo, Ganmaa, Frazier, Kirchberg, Stuart et al., Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia, Pediatrics
Cascella, Rajnik, Cuomo, Dulebohn, Napoli, Features, evaluation and treatment coronavirus (COVID-19)
Cohen, Normile, New SARS-like virus in China triggers alarm, American Association for the Advancement of Science
Giovannucci, Vitamin D and cardiovascular disease, Curr Atherosclerosis Rep
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metabol
Hossein-Nezhad, Holick, Optimize dietary intake of vitamin D: an epigenetic perspective, Curr Opin Clin Nutr Metab Care
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res
Jr, Papadopoulos, Staron, Addesso, Schulman et al., Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease, Am J Respir Crit Care Med
Khoo, Chai, Koenen, Joosten, Netea et al., Translating the role of vitamin D3 in infectious diseases, Crit Rev Microbiol
Kuwabara, Tsugawa, Ao, Ohta, Tanaka, Vitamin D deficiency as the risk of respiratory tract infections in the institutionalized elderly: a prospective 1-year cohort study, Clin Nutr ESPEN
Lai, Shih, Ko, Tang, Hsueh, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges, Int J Antimicrob Agents
Lau, Majumder, Torabi, Saeg, Hoffman et al., Vitamin D insufficiency is prevalent in severe COVID-19, medRxiv
Lips, Which circulating level of 25-hydroxyvitamin D is appropriate?, J Steroid Biochem Mol Biol
Liu, Yan, Xiang, Liu, Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis
Martineau, Jolliffe, Greenberg, Aloia, Bergman et al., Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis, Health Technol Assess
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ
Organization, Clinical management of severe acute respiratory infection when novel coronavirus ( 2019-nCoV) infection is suspected: interim guidance
Peeri, Shrestha, Rahman, Zaki, Tan et al., The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?, Int J Epidemiol
Qian, Yang, Ding, Ma, Wang et al., Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series
Raharusun, Priambada, Budiarti, Agung, Budi, Patterns of COVID-19 mortality and vitamin D: an Indonesian study
Razdan, Singh, Singh, Vitamin D levels and COVID-19 susceptibility: is there any correlation?, Med Drug Dis
Rodriguez-Morales, Cardona-Ospina, Errez-Ocampo, Villamizar-Peña, Holguin-Rivera et al., Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis, Trav Med Infect Dis
Ruan, Yang, Wang, Jiang, Song, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med
Sabetta, Depetrillo, Cipriani, Smardin, Burns et al., Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults, PloS One
Shi, Han, Jiang, Cao, Alwalid et al., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect Dis
Sundaram, Coleman, Vitamin D and influenza, Adv Nutr
Tabrizi, Moosazadeh, Akbari, Dabbaghmanesh, Mohamadkhani et al., High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis, Iran J Med Sci
Zhang, Liu, Potential interventions for novel coronavirus in China: a systemic review, J Med Virol
Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet
Zhu, Zhang, Li, Yang, Song, China Novel Coronavirus I, Research T (2020) A novel coronavirus from patients with pneumonia in China, N Engl J Med
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit